–
Illustration – The Jacques Cartier private hospital in Massy (Essonne) is organizing on Monday March 15, 2021, a morning of information and free screening for colorectal cancer (© Julien Bonnet)
Screening before it’s too late is the goal of Blue mars. Like Pink October for breast cancer, Blue Mars is a month consecrated to the sensitization at screening of cancer colorectal.
It is in this context that theJacques Cartier private hospital of Massy (Essonne) is organizing on Monday March 15, 2021, a information morning and of free screening of cancer colorectal March 15, 2021 between 8:30 a.m. and 2 p.m.
The establishment offers the general public to meet Dr. Hébert, gastroenterologist and hepatologist for a free consultation, without an appointment.
The second deadliest cancer in France
Colorectal cancer affects nearly 43,000 people in France each year. It is responsible for nearly 17,000 deaths per year.
Concretely, colorectal cancer is a malignant tumor of the last part of the digestive tract. It grows slowly inside the colon or rectum, most often from small lesions called polyps or adenomas.
The proliferation of abnormal cells that make up the tumor creates an outgrowth that will gradually block the colon. This cancer is the second deadliest in France. Yet, if caught early, it is cured in 9 out of 10 cases.
A number of diagnoses that decreased in 2020
Thus the colorectal cancer screening test concerns women and men, aged 50 to 74 years. Every two years, the people concerned receive a letter to present to their doctor who will give them the screening test.
However, last year, due to the Covid-19 pandemic, the number of colorectal cancer diagnoses decreased by 23% compared to 2019.
This year, the regional cancer screening coordination center (CRCDC) is therefore working hard to promote screening, reminding that the earlier a cancer is detected, the more effective its treatment.
An effective, fast, painless test to do at home
Since 2015, a simple, rapid and painless immunological test can be carried out yourself at home, thus avoiding late management, because colorectal cancer often progresses, initially, without symptoms or noticeable signs.
The test can detect the presence of blood in the stool. It consists of taking a stool sample and sending it to the medical biology laboratory whose address is indicated on the envelope provided with the test.
If the result of this test is positive (about 4.5% of cases), this does not attest to the presence of cancer, but it does reveal the presence of blood in the stool. A doctor will then order a colonoscopy to detect any lesions in the colon or rectum and, if so, to treat them.
–